These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 26692431)
1. Pharmacotherapy of obsessive-compulsive disorder during pregnancy: a clinical approach. Uguz F Braz J Psychiatry; 2015; 37(4):334-42. PubMed ID: 26692431 [TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy for obsessive compulsive disorder in clinical practice - Data of 842 inpatients from the International AMSP Project between 1994 and 2012. Poppe C; Müller ST; Greil W; Walder A; Grohmann R; Stübner S J Affect Disord; 2016 Aug; 200():89-96. PubMed ID: 27130958 [TBL] [Abstract][Full Text] [Related]
3. Drug treatment of obsessive-compulsive disorder. Kellner M Dialogues Clin Neurosci; 2010; 12(2):187-97. PubMed ID: 20623923 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological management of obsessive-compulsive disorder: a review for clinicians. McDonough M; Kennedy N Harv Rev Psychiatry; 2002; 10(3):127-37. PubMed ID: 12023928 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers. Van Ameringen M; Simpson W; Patterson B; Dell'Osso B; Fineberg N; Hollander E; Hranov L; Hranov G; Lochner C; Karamustafalioglu O; Marazziti D; Menchon JM; Nicolini H; Pallanti S; Stein DJ; Zohar J J Psychopharmacol; 2014 Jun; 28(6):596-602. PubMed ID: 24429223 [TBL] [Abstract][Full Text] [Related]
7. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy. Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206 [TBL] [Abstract][Full Text] [Related]
8. An update on the pharmacological treatment of obsessive-compulsive disorder. Fontenelle LF; Nascimento AL; Mendlowicz MV; Shavitt RG; Versiani M Expert Opin Pharmacother; 2007 Apr; 8(5):563-83. PubMed ID: 17376013 [TBL] [Abstract][Full Text] [Related]
9. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD). Del Casale A; Sorice S; Padovano A; Simmaco M; Ferracuti S; Lamis DA; Rapinesi C; Sani G; Girardi P; Kotzalidis GD; Pompili M Curr Neuropharmacol; 2019; 17(8):710-736. PubMed ID: 30101713 [TBL] [Abstract][Full Text] [Related]
10. The future of pharmacotherapy for obsessive-compulsive disorder may lie in a better understanding of its heterogeneity. Brakoulias V Expert Opin Pharmacother; 2014 Jul; 15(10):1321-3. PubMed ID: 24866422 [TBL] [Abstract][Full Text] [Related]
11. An updated review of antidepressants with marked serotonergic effects in obsessive-compulsive disorder. Pizarro M; Fontenelle LF; Paravidino DC; Yücel M; Miguel EC; de Menezes GB Expert Opin Pharmacother; 2014 Jul; 15(10):1391-401. PubMed ID: 24766145 [TBL] [Abstract][Full Text] [Related]
12. Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms? A systematic review. Sareen J; Kirshner A; Lander M; Kjernisted KD; Eleff MK; Reiss JP J Affect Disord; 2004 Oct; 82(2):167-74. PubMed ID: 15488245 [TBL] [Abstract][Full Text] [Related]
13. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies]. Ammar G; Naja WJ; Pelissolo A Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852 [TBL] [Abstract][Full Text] [Related]